🇺🇸 FDA
Patent

US 8399421

Treatment for neuropathic pain due to spinal cord injury

granted A61KA61K31/7052A61P

Quick answer

US patent 8399421 (Treatment for neuropathic pain due to spinal cord injury) held by The Board of Regents of the University of Texas System expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/7052, A61P, A61P29/00